Chris Gabrieli, a partner emeritus associated with Bessemer's Cambridge, Mass. office, joined the firm in 1986 to launch its healthcare practice. In 25 years of investing with Bessemer, he invested broadly in healthcare and biotechnology. Chris is no longer an investor in new opportunities with Bessemer but remains actively involved in legacy portfolio investments including biotech companies AVEO Pharmaceuticals, Proteon, and Oxagen as well as medical device companies Fractyl and Accuvein and digital textbook pioneer Flat World Knowledge.
Prior to his career at Bessemer, Chris co-founded and served as CEO of GMIS, a healthcare software company he helped build, take public and ultimately sell to the leading industry consolidator McKesson. Bessemer was an investor in GMIS.
Chris graduated from Harvard College with an AB in history and science and completed two years of the Columbia College of Physicians & Surgeons M.D. program. He is now pursuing a second career in non-profit education innovation and is a Lecturer at the Harvard Graduate School of Education.